Alex Stewart
Acute Care · Shreveport, LANPI 1063963890
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 34.0% of the total. Reporting peaked in 2024 at $1,197 and has fallen 53.2% since, to $560 in 2025.
Across 87 payments — averaging $34.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$648
- Kestra Medical Technology Services, Inc.$611
- Abiomed$187
- Silk Road Medical, Inc.$162
- Cordis US CORP.$66
- plus $313 from 9 others
What the payments were for
- Food & beverage$2,80693%
- Education$2047%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $1,023 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $648 |
| Kestra Medical Technology Services, Inc. | 24 | $611 |
| Abiomed | 7 | $187 |
| Silk Road Medical, Inc. | 1 | $162 |
| Cordis US CORP. | 2 | $66 |
| Daiichi Sankyo Inc. | 3 | $65 |
| AstraZeneca | 3 | $48 |
| Boehringer Ingelheim | 2 | $38 |
| Atricure, Inc. | 1 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Boston Scientific | 2 | $30 |
| Lilly USA, LLC | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Merck | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,010 in reported general payments places this provider in the 85th percentile of 248 acute care providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 11 | $128 |
| ClopidogrelClopidogrel Bisulfate | 20 | $52 |
| Rosuvastatin Calcium | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other acute care in Shreveport
- Brinton FegleyShreveport$61K
- Jeremy DavisShreveport$35K
- Heather MecomShreveport$17K
- Mary HireShreveport$11K
- Sammi SmithShreveport$10K
- Heather HebertShreveport$9K
- Richard ChoateShreveport$7K
- Jennifer NinhShreveport$6K
- Laurie SimmonsShreveport$5K
- Brandy RambinShreveport$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.